Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)
Study Identifier
P12-764
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Protocol and Statistical Analysis Plan
Available Language(s): English
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
16 - 99 Years
Protocol Summary
This study of adalimumab (Humira) will be conducted to clarify the following with regard to the treatment of ankylosing spondylitis with this drug:
- Unknown adverse drug reactions (especially important adverse drug reactions)
- Incidence and conditions of occurrence of adverse reactions in the clinical setting
- Factors that may affect the safety and effectiveness of Humira
Study Locations
Location
Status
Location
Nagoya City University Hospital
Nagoya, Aichi-ken, Japan, 467-8602
Status
Not applicable
Location
Kurume University Hospital
Kurume-shi, Fukuoka, Japan, 830-0011
Status
Not applicable
Location
Gunma University Hospital
Maebashi, Gunma, Japan, 371-8511
Status
Not applicable
Location
Hyogo College of Medicine Hosp
Nishinomiya, Hyōgo, Japan, 663-8501
Status
Not applicable
Location
Yokohama City Univ Medical Ctr
Yokohama, Kanagawa, Japan, 232-0024
Status
Not applicable
Location
Nagasaki University Hospital
Nagasaki, Nagasaki, Japan, 〒852-8102
Status
Not applicable
Showing {first} - {last} of {total} Results